News – Corbotics

Corbotics starts Clinical Trial

10-10-2024, Utrecht

Today, a clinical study was started at the University Hospital UMC Utrecht (The Netherlands) in which the disruptive echo robot of the Dutch start-up Corbotics will be validated for effectiveness and safety on a group of 300 patients in total. This so-called multi-center study also involves the Dutch hospitals LUMC, OLVG, Haga, Isala and Catharina.

This project, “BBE-MVP”, is co-sponsored by the EU with the Kansen voor West 3 Grant.

Corbotics Secures Additional Funding

January 2024, Delft

We are glad to announce that Corbotics B.V. added a committed investor EoY2023 and secured in Q1/2024 both a €500K grant of Kansen voor West and a softloan of Rabobank adding to a total of €1.1 Mio. These funds enable Corbotics to further develop its groundbreaking cardiac echo robot, execute Clinical Trials at multiple selected Clinical Centers and to prepare the planned Audits by its selected Notified Body. This project is co-funded by the European Union.

Corbotics wins STZ Innovation Challenge 2023

12-10-2023, Utrecht

Dutch Minister Ernst Kuipers of Health, Welfare and Sport has awarded the 2023 STZ innovation award to Corbotics BV on behalf of STZ, the united 27 top clinical hospitals in the Netherlands.
Corbotics has been given this award for its groundbreaking automated echo device which is autonomously capable of making echo images of the heart (Trans Thoracic Echocardiogram, TTE).

Considering originality, feasibility and impact on health care, the Jury selected Corbotics as winner out of 115 contestants. Due to increased population ageing and the fact that staff cannot keep up with the related growing demand of heart examinations, the Jury acknowledged that Corbotics’ disruptive medical device will be a game changer to overcome this fast growing capacity shortage.
The award was collected on 12 October 2023, by Dr. Eelko Ronner, Cardiologist at Reinier de Graaff Hospitaal in Delft and Adriaan van Donk, CEO of Corbotics.